47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.7 - Wholesale trade of motor vehicles, including motorcycles, and parts and accessories for them
46.75.Z - Wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
58.19 - Other publishing activities, excluding software publishing
58.19.Z - Other publishing activities, excluding software publishing
59.11.Z - Activities related to the production of films, video recordings, and television programs
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,2 | -0,9 | -0,2 | 76,2 |
EBITDA | 0 | 0,5 | 1,4 | 176,4 |
Short time liabilities | 10,8 | 9,2 | 12 | 31,1 |
Equity capital | 2,7 | 2 | 7,2 | 263,6 |
Operating profit (EBIT) | -0,7 | -0,4 | 0,6 | 263,7 |
Assets | 14,1 | 17,4 | 19,9 | 13,9 |
Net profit (loss) | -1,1 | -0,8 | -0,3 | 62,8 |
Cash | 0,5 | 0,7 | 0,6 | -9,5 |
Liabilities and provisions for liabilities | 11,3 | 15,5 | 12,7 | -18,1 |
Net income from sale | 50,1 | 59,9 | 76 | 26,9 |
Working assets | 10,4 | 12,9 | 16,6 | 29,2 |
Depreciation | 0,7 | 0,9 | 0,8 | -4,8 |
% | % | % | p.p. | |
Profitability of capital | -38,7 | -38,6 | -4 | 34,6 |
Equity capital to total assets | 19,5 | 11,3 | 36,2 | 24,9 |
Gross profit margin | -2,4 | -1,5 | -0,3 | 1,2 |
EBITDA Margin | 0 | 0,9 | 1,9 | 1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 79 | 56 | 58 | 2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane